Trials / Unknown
UnknownNCT05835856
e-VITA: European-Japanese Virtual Coach for Smart Ageing (WAVE II)
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 240 (estimated)
- Sponsor
- Istituto Nazionale di Ricovero e Cura per Anziani · Academic / Other
- Sex
- All
- Age
- 65 Years
- Healthy volunteers
- Not accepted
Summary
The study is a multicentre Proof-of-Concept. The general objective of the e-VITA project is to develop a personalized virtual coach capable of interacting with its elderly interlocutor. The experimentation will be carried out in 4 sites: Italy, France, Germany and Japan.
Detailed description
The general objective of the e-VITA project is to improve well-being for older adults and thereby promote active and healthy ageing, contribute to independent living, and reduce risks of social exclusion of older adults by making use a virtual coach by 240 healthy older adults recruited from Europe (France, Germany and Italy) and Japan. The study is a multicenter Proof-of-Concept study with a duration of the intervention of six months. The multidisciplinary consortium collaborating in this project will develop an innovative ICT-based virtual coaching system to detect subtle changes in physical, cognitive, psychological and social domains of older adult's daily life. The e-VITA virtual coach will thus provide personalized recommendations and interventions, for sustainable wellbeing in a smart living environment at home. The different components of the system are: * Coaches, consisting of social robots, that will interact with the users and are guided by apps; * Sensors (both wearable and domestic) to detect physiological parameters, physical activities, and behavior of the users; these sensors are: the Huawei smart band (wearable), the NeU device (wearable), and the DeltaDore system (domestic). * Smartphones (the chatbot to provide insights, suggestion, and stimulation about healthy nutrition and physical exercise; the social platform to encourage users to share their interests). These components (coaches, sensors, chatbot and social platform) together with a main software named Use Cases Configurator (UCC) constitute the Virtual Coach.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Virtual coach with NAO robot | The coaching device used is the softbank NAO 5 and NAO 6 humanoid interactive mobile robot. These robot platform allows multimodal natural language interaction and robot autonomous movement. |
| DEVICE | Virtual coach with Google Nest Hub (2e generation) group | The coaching device used is Google Nest Hub (2e generation). This is a connected speaker enriched with a 7-chip touch screen. It has a loudspeaker and 3 microphones, making interaction possible. |
| DEVICE | Virtual coach with Gatebox device | The coaching device used is the Gatebox, a hologram like device which the user can interact. There are internal sensors such as a camera and a microphone allow the user to converse with the projected character. It connects to the Internet via a wireless LAN. With infrared rays and Bluetooth, it can also be connected to household appliances and other devices. |
| DEVICE | virtual coach with CelesTE robot | The coaching device used is the CelesTE robot, a prayer companion designed for Christian Catholic users.The intended main function of CelesTE is to be a "guardian angel", especially thought for elderly people. It can be a prayer companion, and contains a vast number of teachings, including the whole Bible. Its AI is capable of keeping a short conversation, in which the user may ask and receive an answer about a sensitive topic (such as happiness, death, faith, etc.). It can also printout a selection of contents. The coaching device CelesTE will be substituted by DarumaTO for the Japanese centers. |
| OTHER | booklet | Participant in the control group will receive a booklet containing information and activities on well-being |
Timeline
- Start date
- 2023-07-24
- Primary completion
- 2024-03-30
- Completion
- 2024-03-30
- First posted
- 2023-04-28
- Last updated
- 2023-10-27
Locations
4 sites across 4 countries: France, Germany, Italy, Japan
Source: ClinicalTrials.gov record NCT05835856. Inclusion in this directory is not an endorsement.